ENLV
Enlivex Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.80 / 10
Underperform
With technical parameters scoring 2.8/10, the profile indicates challenging technical structure. Encouraging developments in Marubozu White are counterbalanced by RSI Overbought, Long Upper Shadow, and Long Lower Shadow. Technical outlook: cautious.
Analysis Checks(1/4)
Long Upper Shadow
Score1/10
Win Rate39.68%
Hist. Signals63
Avg Return-1.29%
Score1/10
Win Rate39.68%
Hist. Signals63
Avg Return-1.29%
RSI Overbought
Score1/10
Win Rate29.41%
Hist. Signals17
Avg Return-7.33%
Score1/10
Win Rate29.41%
Hist. Signals17
Avg Return-7.33%
Long Lower Shadow
Score1.29/10
Win Rate41.38%
Hist. Signals58
Avg Return-0.84%
Score1.29/10
Win Rate41.38%
Hist. Signals58
Avg Return-0.84%
Marubozu White
Score7.92/10
Win Rate65.00%
Hist. Signals20
Avg Return5.98%
Score7.92/10
Win Rate65.00%
Hist. Signals20
Avg Return5.98%
Long Upper Shadow
Score1/10
Win Rate39.68%
Hist. Signals63
Avg Return-1.29%
Score1/10
Win Rate39.68%
Hist. Signals63
Avg Return-1.29%
Long Lower Shadow
Score1.29/10
Win Rate41.38%
Hist. Signals58
Avg Return-0.84%
Score1.29/10
Win Rate41.38%
Hist. Signals58
Avg Return-0.84%
RSI Overbought
Score1/10
Win Rate29.41%
Hist. Signals17
Avg Return-7.33%
Score1/10
Win Rate29.41%
Hist. Signals17
Avg Return-7.33%
Marubozu White
Score7.92/10
Win Rate65.00%
Hist. Signals20
Avg Return5.98%
Score7.92/10
Win Rate65.00%
Hist. Signals20
Avg Return5.98%
Technical Analysis of ENLV?
- ENLV presents a Underperform setup with a Technical Score of 2.80/10. Key technical indicators highlight an RSI of 63.55 and a MACD of 0.02, with the trend anchored by the 50-Day SMA at 0.95. Traders should monitor key support at 1.06 and resistance at 1.26.
